Search

Your search keyword '"Ahuka-Mundeke, Steve"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Ahuka-Mundeke, Steve" Remove constraint Author: "Ahuka-Mundeke, Steve" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
144 results on '"Ahuka-Mundeke, Steve"'

Search Results

1. Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo

2. Co-Circulating Monkeypox and Swinepox Viruses, Democratic Republic of the Congo, 2022

3. COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020–2022

4. Clade I-Associated Mpox Cases Associated with Sexual Contact, the Democratic Republic of the Congo

5. Fatal meningoencephalitis associated with Ebola virus persistence in two survivors of Ebola virus disease in the Democratic Republic of the Congo: a case report study

6. Sensitive poliovirus detection using nested PCR and nanopore sequencing: a prospective validation study

7. Dysglycaemia in Ebola virus disease: a retrospective analysis from the 2018 to 2020 outbreak

8. Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study

10. Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study

11. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

12. 2020 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation

13. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020--April 2021), Democratic Republic of the Congo

15. Head-to-head comparison of diagnostic accuracy of four Ebola virus disease rapid diagnostic tests versus GeneXpert® in eastern Democratic Republic of the Congo outbreaks: a prospective observational study

16. A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field

17. Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020–January 2022

18. Differential symptomology of possible and confirmed Ebola virus disease infection in the Democratic Republic of the Congo: a retrospective cohort study

19. Virus kinetics and biochemical derangements among children with Ebolavirus disease

20. Field performance of three Ebola rapid diagnostic tests used during the 2018–20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study

21. Postmortem Surveillance for Ebola Virus Using OraQuick Ebola Rapid Diagnostic Tests, Eastern Democratic Republic of the Congo, 2019-2020

22. Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020

23. Evaluation of Early Warning, Alert and Response System for Ebola Virus Disease, Democratic Republic of the Congo, 2018-2020

24. Ebola Virus Disease Outbreak — Democratic Republic of the Congo, August 2018–November 2019

25. Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo

26. Rhabdomyolysis, Acute Kidney Injury, and Mortality in Ebola Virus Disease: Retrospective Analysis of Cases From the Eastern Democratic Republic of the Congo, 2019.

27. Synergistic effects of novel penicillin-binding protein 1A amino acid substitutions contribute to high-level amoxicillin resistance of Helicobacter pylori.

28. Knowledge, attitudes, practices, and perception of COVID-19 preventive measures among adult residents of Matadi (Democratic Republic of the Congo) after the third epidemic wave.

29. An ounce of prevention is better: Monitoring wildlife health as a tool for pandemic prevention.

30. Detection of the Lassa Virus in a Group of Odontogenic Bone Tumor Tissues.

32. Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

33. Real-time predictions of the 2018–2019 Ebola virus disease outbreak in the Democratic Republic of the Congo using Hawkes point process models

34. Estimating the impact of violent events on transmission in Ebola virus disease outbreak, Democratic Republic of the Congo, 2018–2019

35. 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation

36. Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment

37. Structural Features and Genetic Diversity in Gag Gene of Rare HIV-1 Subtypes from the Democratic Republic of Congo.

38. Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report.

39. Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015-2017

40. The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the blood transfusion national center in Kinshasa

41. Where are the Ebola diagnostics from last time?

42. Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting.

43. Cost-effectiveness of incorporating Ebola prediction score tools and rapid diagnostic tests into a screening algorithm: A decision analytic model.

44. Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.

46. Use of Mpox Multiplex Serology in the Identification of Cases and Outbreak Investigations in the Democratic Republic of the Congo (DRC).

47. Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria

48. High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.

49. High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May–October 2021) in Matadi, Democratic Republic of the Congo.

50. Development of Ebola virus disease prediction scores: Screening tools for Ebola suspects at the triage-point during an outbreak.

Catalog

Books, media, physical & digital resources